Accès ouvert
2025
article
OpenAlex
Nicolas Bonnet, Maria Rosario Capeding, Léa Siegwald, Marc Garcia‐Garcerà et autres
In this randomized, double-blind controlled trial, 182 Filipino children aged 2-3 years received either an experimental young child formula (EYCF) containing a combination of Limosilactobacillus reuteri DSM 17938 and galacto-oligosaccharides (GOS; n = 91) or a minimally fortified milk (CM; n = …
ch, ph, dk
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Nick M. A. Schubert, Shuyang Yao, Maryam Kazemi Naeini, Natalia Trpchevska et autres
Tinnitus is a distressing condition affecting millions of people worldwide, yet treatment options remain very limited. Molecular evidence on the cellular origins of tinnitus in humans is lacking. Here, we performed a genome-wide association meta-analysis of clinically diagnosed and self-reported tinnitus on …
nl, se, gb, us, fi, ee, dk, it, is, de
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Nicolas Bonnet, Maria Rosario Capeding, Léa Siegwald, Marc Garcia‐Garcerà et autres
Abstract Key Points This section will be completed further Importance Toddlerhood is a key window of opportunity for development of musculoskeletal system and microbiome. In this study we tested the efficacy of a synbiotic-based young child formula on bone and muscle strength …
ch, ph, dk
(code pays fourni par la source)
Accès ouvert
2024
erratum
OpenAlex
Elisabet Alexandra Frick, Valur Emilsson, Þórarinn Jónmundsson, Anna E. Steindorsdottir et autres
In the version of this article initially published, in Fig. 4a, the blue data points were presented as odds ratios in the same panels and on the same scale as the yellow data points (hazard ratios), which was incorrect. The blue data …
is, us, es
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Elisabet Alexandra Frick, Valur Emilsson, Þórarinn Jónmundsson, Anna E. Steindorsdottir et autres
A deeper understanding of the molecular processes underlying late-onset Alzheimer’s disease (LOAD) could aid in biomarker and drug target discovery. Using high-throughput serum proteomics in the prospective population-based Age, Gene/Environment Susceptibility–Reykjavik Study (AGES) cohort of 5,127 older Icelandic adults (mean age, 76.6 …
is, us, es
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Yuguang Gao, L. C. M., André Goedegebure, Antti A. Mäkitie et autres
Hearing loss is one of the top contributors to years lived with disability and is a risk factor for dementia. Molecular evidence on the cellular origins of hearing loss in humans is growing. Here, we performed a genome-wide association meta-analysis of clinically …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Muralidharan Sargurupremraj, Aïcha Soumaré, Joshua C. Bis, Ida L. Surakka et autres
Importance: Vascular disease is a treatable contributor to dementia risk, but the role of specific markers remains unclear, making prevention strategies uncertain. Objective: To investigate the causal association between white matter hyperintensity (WMH) burden, clinical stroke, blood pressure (BP), and dementia risk, …
fr, us, ee, nl, is, gb, cl, no
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Viktor Hamrefors, Fredrik Kahn, Madlene Holmqvist, Katherine B Carlson et autres
Postural Orthostatic Tachycardia Syndrome (POTS) reflects an autonomic dysfunction, which can occur as a complication to COVID-19. Our aim was to examine gastrointestinal symptoms and gut microbiota composition in patients with POTS and post-acute COVID-19 syndrome (PACS), compared with controls. POTS patients …
se, dk
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Valborg Guðmundsdóttir, Elisabet Alexandra Frick, Valur Emilsson, Þórarinn Jónmundsson et autres
ch, us, is, es, cn
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Elisabet Alexandra Frick, Valur Emilsson, Þórarinn Jónmundsson, Anna E. Steindorsdottir et autres
Summary The current demand for early intervention, prevention, and treatment of late onset Alzheimer’s disease (LOAD) warrants deeper understanding of the underlying molecular processes which could contribute to biomarker and drug target discovery. Utilizing high-throughput proteomic measurements in serum from a prospective …
is, us, es
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Muralidharan Sargurupremraj, Aïcha Soumaré, Joshua C. Bis, Ida L. Surakka et autres
Abstract Importance There is increasing recognition that vascular disease, which can be treated, is a key contributor to dementia risk. However, the contribution of specific markers of vascular disease is unclear and, as a consequence, optimal prevention strategies remain unclear. Objective To …
fr, us, ee, nl, is, gb, no
(code pays fourni par la source)
2022
article
OpenAlex
Bernard Fongang, Muralidharan Sargurupremraj, Xueqiu Jian, Aniket Mishra et autres
Abstract Background Genome‐wide association studies (GWAS) have identified more than 40 genetic loci associated with Alzheimer’s disease (AD). Although vascular dementia (VaD) is the second most common type of dementia after AD, the genetic contribution to VaD is understudied. We hypothesize that …
us, fr, hk, nl, au, is, gb, no, sg, es, il
(code pays fourni par la source)